SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-24-059536
Filing Date
2024-07-05
Accepted
2024-07-05 16:01:06
Documents
10
Period of Report
2024-08-07

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ea0208996-def14a_aditxt.htm DEF 14A 1711901
2 GRAPHIC image_001.jpg GRAPHIC 2835
3 GRAPHIC image_002.jpg GRAPHIC 9605
4 GRAPHIC image_003.jpg GRAPHIC 2696
5 GRAPHIC image_004.jpg GRAPHIC 2603
6 GRAPHIC image_005.jpg GRAPHIC 1941
7 GRAPHIC image_006.jpg GRAPHIC 2820
8 GRAPHIC image_007.jpg GRAPHIC 2823
9 GRAPHIC image_008.jpg GRAPHIC 584203
10 GRAPHIC image_009.jpg GRAPHIC 338689
  Complete submission text file 0001213900-24-059536.txt   3020114
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39336 | Film No.: 241102608
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)